- United States
- /
- Professional Services
- /
- NYSE:EFX
3 US Stocks Trading At Estimated Discounts Of Up To 49.1%
Reviewed by Simply Wall St
As the U.S. stock market continues to rally, buoyed by President Trump's recent executive actions and a strong performance in major indices like the Dow Jones and S&P 500, investors are on the lookout for opportunities amid these shifting economic policies. In such an environment, identifying undervalued stocks can be crucial for those looking to capitalize on potential market inefficiencies, especially when certain equities are trading at significant discounts compared to their estimated intrinsic values.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
Name | Current Price | Fair Value (Est) | Discount (Est) |
Atlantic Union Bankshares (NYSE:AUB) | $38.27 | $75.53 | 49.3% |
First Solar (NasdaqGS:FSLR) | $183.51 | $357.85 | 48.7% |
Berkshire Hills Bancorp (NYSE:BHLB) | $28.72 | $56.94 | 49.6% |
German American Bancorp (NasdaqGS:GABC) | $39.76 | $78.06 | 49.1% |
Heartland Financial USA (NasdaqGS:HTLF) | $66.48 | $130.08 | 48.9% |
Equity Bancshares (NYSE:EQBK) | $43.76 | $85.93 | 49.1% |
Privia Health Group (NasdaqGS:PRVA) | $22.73 | $44.59 | 49% |
Verra Mobility (NasdaqCM:VRRM) | $26.08 | $52.02 | 49.9% |
Equifax (NYSE:EFX) | $272.27 | $534.41 | 49.1% |
Coeur Mining (NYSE:CDE) | $6.37 | $12.61 | 49.5% |
Let's explore several standout options from the results in the screener.
Rocket Lab USA (NasdaqCM:RKLB)
Overview: Rocket Lab USA, Inc. is a space company offering launch services and space systems solutions for the space and defense industries, with a market cap of approximately $11.99 billion.
Operations: The company's revenue is derived from two primary segments: Space Systems, contributing $272.33 million, and Launch Services, generating $91.49 million.
Estimated Discount To Fair Value: 15.1%
Rocket Lab USA is trading at US$31.27, below its estimated fair value of US$36.82, suggesting it may be undervalued based on cash flows. Despite significant insider selling and a volatile share price, the company is expected to achieve profitability within three years with revenue growth forecasted at 27% annually, surpassing market averages. Recent contracts with NASA and the U.S. Department of Defense highlight Rocket Lab's strategic positioning in the space industry as it expands its launch capabilities.
- Our comprehensive growth report raises the possibility that Rocket Lab USA is poised for substantial financial growth.
- Delve into the full analysis health report here for a deeper understanding of Rocket Lab USA.
Brinker International (NYSE:EAT)
Overview: Brinker International, Inc. operates and franchises casual dining restaurants both in the United States and internationally, with a market cap of $6.40 billion.
Operations: Brinker International's revenue segments consist of $4.04 billion from Chili's and $500 million from Maggiano's.
Estimated Discount To Fair Value: 41.8%
Brinker International is trading at US$153.63, significantly below its estimated fair value of US$264.08, indicating potential undervaluation based on cash flows. The company has seen substantial earnings growth, with net income rising to US$38.5 million from US$7.2 million year-over-year in Q1 2024. Despite high debt levels and recent insider selling, Brinker forecasts robust annual profit growth of over 21%, although revenue growth lags behind market averages at 5.2%.
- Our earnings growth report unveils the potential for significant increases in Brinker International's future results.
- Unlock comprehensive insights into our analysis of Brinker International stock in this financial health report.
Equifax (NYSE:EFX)
Overview: Equifax Inc. is a data, analytics, and technology company with a market capitalization of approximately $32.58 billion.
Operations: The company's revenue is derived from three main segments: International at $1.34 billion, Workforce Solutions at $2.40 billion, and U.S. Information Solutions at $1.85 billion.
Estimated Discount To Fair Value: 49.1%
Equifax is trading at US$272.27, well below its estimated fair value of US$534.41, suggesting it might be undervalued based on cash flows. With earnings projected to grow significantly at 23.8% annually, surpassing the US market growth rate of 14.9%, Equifax shows strong potential despite high debt levels. Recent strategic moves include bolt-on acquisitions to bolster core operations and partnerships enhancing service offerings like The Work Number®, supporting robust cash flow generation and shareholder returns.
- The growth report we've compiled suggests that Equifax's future prospects could be on the up.
- Click to explore a detailed breakdown of our findings in Equifax's balance sheet health report.
Make It Happen
- Explore the 168 names from our Undervalued US Stocks Based On Cash Flows screener here.
- Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
- Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.
Seeking Other Investments?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Equifax might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:EFX
High growth potential with mediocre balance sheet.